IL88810A - 1, 2, 3, 4, 6, 7, 8, 12b-octahydro 7-(mercaptomethyl)- 6-oxopyrido (2,1-a) (2)- benzazepine-4-carboxylic acid, esters thereof and pharmaceutical compositions containing same - Google Patents

1, 2, 3, 4, 6, 7, 8, 12b-octahydro 7-(mercaptomethyl)- 6-oxopyrido (2,1-a) (2)- benzazepine-4-carboxylic acid, esters thereof and pharmaceutical compositions containing same

Info

Publication number
IL88810A
IL88810A IL88810A IL8881088A IL88810A IL 88810 A IL88810 A IL 88810A IL 88810 A IL88810 A IL 88810A IL 8881088 A IL8881088 A IL 8881088A IL 88810 A IL88810 A IL 88810A
Authority
IL
Israel
Prior art keywords
oxopyrido
benzazepine
mercaptomethyl
octahydro
esters
Prior art date
Application number
IL88810A
Other languages
English (en)
Other versions
IL88810A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL88810A0 publication Critical patent/IL88810A0/xx
Publication of IL88810A publication Critical patent/IL88810A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL88810A 1987-12-30 1988-12-27 1, 2, 3, 4, 6, 7, 8, 12b-octahydro 7-(mercaptomethyl)- 6-oxopyrido (2,1-a) (2)- benzazepine-4-carboxylic acid, esters thereof and pharmaceutical compositions containing same IL88810A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/139,485 US4824832A (en) 1987-12-30 1987-12-30 Sulfhydryl containing tricyclic lactams and their pharmacological methods of use

Publications (2)

Publication Number Publication Date
IL88810A0 IL88810A0 (en) 1989-07-31
IL88810A true IL88810A (en) 1993-08-18

Family

ID=22486887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88810A IL88810A (en) 1987-12-30 1988-12-27 1, 2, 3, 4, 6, 7, 8, 12b-octahydro 7-(mercaptomethyl)- 6-oxopyrido (2,1-a) (2)- benzazepine-4-carboxylic acid, esters thereof and pharmaceutical compositions containing same

Country Status (18)

Country Link
US (1) US4824832A (xx)
EP (1) EP0322914B1 (xx)
JP (1) JP2681291B2 (xx)
KR (1) KR0128158B1 (xx)
CN (1) CN1034721A (xx)
AT (1) ATE100453T1 (xx)
AU (1) AU611984B2 (xx)
CA (1) CA1336191C (xx)
DE (1) DE3887307T2 (xx)
DK (1) DK725988A (xx)
ES (1) ES2061621T3 (xx)
FI (1) FI886005A (xx)
HU (2) HU204050B (xx)
IL (1) IL88810A (xx)
NO (1) NO885812L (xx)
NZ (1) NZ227432A (xx)
PT (1) PT89346B (xx)
ZA (1) ZA889542B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
ATE158303T1 (de) * 1990-12-21 1997-10-15 Merrell Pharma Inc Neue trizyklische amino- und nitro verbindungen mit ace-hemmenden eigenschaften
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
CA2078758C (en) * 1991-09-27 2003-12-09 Alan M. Warshawsky 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
DE69317764T2 (de) * 1992-02-14 1998-07-30 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
US5646276A (en) * 1992-05-13 1997-07-08 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5420271A (en) * 1992-08-24 1995-05-30 Merrell Dow Pharmaceuticals, Inc. 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
ES2155852T3 (es) * 1992-10-30 2001-06-01 Merrell Pharma Inc Derivados de lactama biciclica de mercaptoacetilamida utiles como inhibidores de encefalinasa y eca.
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
JP3547749B2 (ja) * 1993-11-19 2004-07-28 メレルファーマス−ティカルズ インコーポレイテッド （ｓ）−１−［２（ｓ）−（１，３−ジヒドロ−１，３−ジオキソ−イソインド−２−イル）−１−オキソ−３−フェニルプロピル］−１，２，３，４−テトラヒドロ−２−ピリジン−カルボン酸メチルエステル及びその中間体類の新規な製法
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
CN1069317C (zh) * 1994-02-14 2001-08-08 默里尔药物公司 用作脑啡肽酶抑制剂的新的1,2－二氢化茚－2－巯基乙酰胺二硫化物衍生物
CN1046512C (zh) * 1994-02-14 1999-11-17 默里尔药物公司 巯基乙酰胺二硫化物衍生物，其制备方法及含有它们的药物组合物
WO1995021857A1 (en) * 1994-02-14 1995-08-17 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
EP0750631B1 (en) * 1994-02-14 2000-04-05 Merrell Pharmaceuticals Inc. Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
JPH09510476A (ja) * 1994-03-24 1997-10-21 メリル・フアーマシユウテイカルズ・インコーポレイテツド 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のアミノアセチルメルカプト誘導体
CN1144482A (zh) * 1994-03-24 1997-03-05 默里尔药物公司 降低胆固醇、抗动脉粥样硬化和降低甘油三酯的巯基乙酰胺二硫化物衍生物
HU227675B1 (en) * 1994-12-21 2011-11-28 Aventisub Ii Inc Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use
US20030229007A1 (en) * 2002-05-30 2003-12-11 Roberto Levi Form of human renin and its use as a target in treatments for cardiac ischemia and arrhythmia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185680A (en) * 1962-10-16 1965-05-25 American Home Prod Reduced benzodiazepinium compounds
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
CA1337654C (en) * 1986-06-13 1995-11-28 Gary A. Flynn Fused tricyclic lactams as antihypertensive agents

Also Published As

Publication number Publication date
IL88810A0 (en) 1989-07-31
DE3887307D1 (de) 1994-03-03
US4824832A (en) 1989-04-25
FI886005A (fi) 1989-07-01
KR890009927A (ko) 1989-08-04
JPH01203382A (ja) 1989-08-16
HU895880D0 (en) 1990-02-28
AU611984B2 (en) 1991-06-27
JP2681291B2 (ja) 1997-11-26
AU2736888A (en) 1989-07-06
ATE100453T1 (de) 1994-02-15
NO885812L (no) 1989-07-03
NZ227432A (en) 1990-11-27
CN1034721A (zh) 1989-08-16
PT89346B (pt) 1993-08-31
HU204050B (en) 1991-11-28
DK725988D0 (da) 1988-12-28
DE3887307T2 (de) 1994-05-05
ZA889542B (en) 1989-09-27
PT89346A (pt) 1989-12-29
DK725988A (da) 1989-07-01
NO885812D0 (no) 1988-12-29
EP0322914A3 (en) 1990-12-27
HU200181B (en) 1990-04-28
ES2061621T3 (es) 1994-12-16
HUT49137A (en) 1989-08-28
KR0128158B1 (ko) 1998-04-04
EP0322914B1 (en) 1994-01-19
EP0322914A2 (en) 1989-07-05
CA1336191C (en) 1995-07-04

Similar Documents

Publication Publication Date Title
IL88810A (en) 1, 2, 3, 4, 6, 7, 8, 12b-octahydro 7-(mercaptomethyl)- 6-oxopyrido (2,1-a) (2)- benzazepine-4-carboxylic acid, esters thereof and pharmaceutical compositions containing same
IE882929L (en) "immunomodulatory azaspiranes"
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
NZ212750A (en) 3-acylamino-2-azetidinone derivatives useful as intermediates in the preparation of antibacterial agents
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
PL268455A1 (en) The method of manufacture of new derivatives of benzimidazole
DE69019111D1 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
ES8706149A1 (es) Procedimiento para preparar 4h-1-benzopiran-4-onas
PT82032A (en) Process for the preparation of anticonvulsant amino acid derivatives and of pharmaceutical compositions containing the same
BG103194A (en) Pharmaceutical products for the treatment and prevention of diseases caused by the impairment of the vascular endothelial cells
EP0207681A3 (en) Pyrrolidone derivatives
IL75987A (en) Tri-and tetrasubstituted-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
LT2199B (lt) 2-triazolidinono dariniu gavimo budas
DE3063105D1 (en) Clavulanic acid derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.